Rapid Hematological Profiling of the GPNMB/GRN Ratio via Bioelectronic Platform for Early Diagnosis of Parkinson's Disease
Advanced Materials · 2026
DOI: 10.1002/adma.74326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Xiaohong Jiang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biotechnology and Food Engineering, Guangdong Technion-Israel Institute of Technology (GTIIT), Shantou, China. Hauptthemen laut MEDLINE: Parkinson Disease, Membrane Glycoproteins, Biosensing Techniques. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Postdoctoral Overseas Program, Guangdong Provincial and Municipal Joint Youth Fund Project.
Abstract (Originalsprache)
Early blood‐based diagnosis of Parkinson's disease (PD) remains challenging owing to the lack of reliable composite biomarkers and rapid, sensitive, and cost‐effective detection platforms. Here, we report a bioelectronic sensor based on an organic electrochemical transistor (OECT) driven by a laser‐induced graphene (LIG) array. By integrating an alternating‐current (AC)‐mediated LIG rapid incubation system (LRIS), the platform enables multiplexed protein profiling directly from clinical samples within approximately 6 min, with attomolar‐level detection limits. We identify the glycoprotein non‐metastatic melanoma protein B (GPNMB)/granulin (GRN) ratio as a sensitive composite biomarker of neuroinflammatory dysregulation, showing pronounced alterations at early disease stages and complementing α‐synuclein for PD assessment. In PD mouse models spanning mild to severe stages ( n = 32), this ratio correlated with disease progression and enabled the detection of mild neuronal loss. Clinical validation in healthy individuals and patients with PD or prodromal PD ( n = 54) showed that the GPNMB/GRN ratio distinguished patients with PD from healthy controls with 80% sensitivity, 90% specificity, and 85% accuracy. Incorporating α‐synuclein further improved diagnostic accuracy. This biomarker–platform strategy provides a rapid, ultrasensitive, and scalable framework for blood‐based PD screening and early risk assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Biotechnology and Food Engineering, Guangdong Technion-Israel Institute of Technology (GTIIT), Shantou, China.
- Faculty of Biotechnology and Food Engineering, Technion-Israel Institute of Technology (IIT), Haifa, Israel.
- Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
- Department of Neurology, First Affiliated Hospital of Shantou University Medical College, Shantou, China.
- Department of Biology & Guangdong Provincial Key Laboratory of Marine Biotechnology, College of Science, Shantou University, Shantou, Guangdong, China.
- School of Medicine, The Chinese University of Hong Kong, Shenzhen, China.
ORCID-Profile: Jintao Zheng, Hong Du, Cheng Jiang, Sahika Inal, Jiacan Su, Keying Guo
Förderung
- National Natural Science Foundation of China
- Postdoctoral Overseas Program
- Guangdong Provincial and Municipal Joint Youth Fund Project
- Guangdong Provincial Key Platform and Science Project
- GTIIT Startup
- Technion-GTIIT Joint Seeds
- GTIIT Mingsheng Energy Technology Research Fund
- Shenzhen Peacock Team
Zitieren
APA
Jiang, X., Zheng, J., Yu, J., Chen, R., Lai, M., Liang, Z., Zhou, R., Fu, W., Yan, H., Du, H., Segal, E., Jiang, C., Inal, S., Su, J., & Guo, K. (2026). Rapid Hematological Profiling of the GPNMB/GRN Ratio via Bioelectronic Platform for Early Diagnosis of Parkinson's Disease. Advanced Materials. https://doi.org/10.1002/adma.74326
Vancouver
Jiang X, Zheng J, Yu J, Chen R, Lai M, Liang Z, et al. Rapid Hematological Profiling of the GPNMB/GRN Ratio via Bioelectronic Platform for Early Diagnosis of Parkinson's Disease. Advanced Materials. 2026. doi:10.1002/adma.74326
BibTeX
@article{Jiang2026,
author = {Jiang, Xiaohong and Zheng, Jintao and Yu, Jiacheng and Chen, Rui and Lai, Minchao and Liang, Zheng and Zhou, Runzhi and Fu, Weilai and Yan, Haoyang and Du, Hong and Segal, Ester and Jiang, Cheng and Inal, Sahika and Su, Jiacan and Guo, Keying},
title = {Rapid Hematological Profiling of the GPNMB/GRN Ratio via Bioelectronic Platform for Early Diagnosis of Parkinson's Disease},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.74326}
}
EUVIMED